• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pluristem Therapeutics Inc

+ Add to Watchlist

PSTI:US

2.8200 USD 0.0500 1.81%

As of 20:10:00 ET on 08/27/2014.

Snapshot for Pluristem Therapeutics Inc (PSTI)

Open: 2.8000 Day's Range: 2.7899 - 2.8400 Volume: 107,108
Previous Close: 2.7700 52wk Range: 2.5800 - 4.6300 1-Yr Rtn: -5.37%

Stock Chart for PSTI

No chart data available.
  • PSTI:US 2.8300
  • 1D
  • 1M
  • 1Y
2.7700
Interactive PSTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PSTI

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5300
Est. EPS (USD) (06/2014) -0.5870
Est. PEG Ratio -
Market Cap (M USD) 193.46
Shares Outstanding (M) 68.60
30 Day Average Volume 90,306
Price/Book (mrq) 2.9009
Price/Sale (ttm) 294.4621
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PSTI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PSTI

Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.

Zami AbermanChairman/CEOYaky YanayPresident/COO
Boaz Gur-LavieCFO/Secretary
More Company Profile & Key Executives for PSTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil